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Background:
The ABO blood groups result from DNA sequence variations, predominantly single nucleotide and insertion/deletion polymorphisms (SNPs and indels), in the ABO gene encoding a glycosyltransferase. The ABO blood groups A 1 , A 2 , B and O predominantly result from the wild type allele A1 and the major gene variants that are characterized by four diallelic markers (261G>del, 802G>A, 803G>C, 1061C>del). Here, we were interested to evaluate the impact of ABO genotyping compared to ABO phenotyping in paternity testing. Methods: The major ABO alleles were determined by PCR amplification with sequence-specific primers (PCR-SSP) in a representative sample of 1,335 blood donors. The genotypes were compared to the ABO blood groups registered in the blood donor files. Then, the ABO phenotypes and genotypes were determined in 95 paternity trio cases that have been investigated by 12 short tandem repeat (STR) markers before. We compared statistical parameters (PL, paternity likelihood; PE, power of exclusion) of both blood grouping approaches. Results: The prevalence of the major ABO alleles and genotypes corresponded to the expected occurrence of ABO blood groups in a Caucasian population. The low resolution genotyping of 4 diallelic markers revealed a correct genotype-phenotype correlation in 1,331 of 1,335 samples (99.7%). In 60 paternity trios with confirmed paternity of the alleged father based on STR analysis both PL and PE of the ABO genotype was significantly higher than of the ABO phenotype. In 12 of 35 exclusion cases (34.3%) the ABO genotype also excluded the alleged father, whereas the ABO phenotype excluded the alleged father only in 7 cases (20%). Conclusion: In paternity testing ABO genotyping is superior to ABO phenotyping with regard to PL and PE, however, ABO genotyping is not sufficient for valid paternity testing. Due to the much lower mutation rate compared to STR markers, blood group SNPs in addition to anonymous SNPs could be considered for future kinship analysis and genetic identity testing. 
Schlüsselwörter
AB0-Genotypisierung
DNA Isolation and Standard ABO Genotyping by PCR-SSP
DNA was isolated from buffy coats of CPD-anticoagulated whole blood donations using a commercial system (FlexiGene DNA Kit; Qiagen, Hilden, Germany). For ABO blood group genotyping the ABO gene polymorphisms 261G>del (for deletional O alleles), 802G>A (for the non-deletional O allele *O03), 803G>C (for B alleles), and 1061C>del (for A2 alleles) were analyzed in all samples by PCR with sequence specific primers (PCR-SSP) as described previously [11] . The alleles were detected by 8 separate reactions each with allele-specific and internal control primers. According to an optimized protocol only 5 ng DNA were used per reaction [12] . In this lowresolution genotyping approach rare variants with mutations at other sites of the ABO gene are not recognized. Exclusion of the four variant alleles 261del, 802A, 803C, and 1061del indicated the A 1 blood group.
Serologic ABO Blood Grouping ABO blood groups A 1 , A 2 , B and O were determined using lectins and monoclonal antisera (Optima GmbH, Bammental, Germany) in standard hemagglutination tests.
Statistical Analysis
Basic statistical analysis including observed heterozygosity, polymorphic information content (PIC), power of discrimination (PD), PE, and HardyWeinberg equilibrium test was performed using the PowerStatsV12 Excel workbook template developed and provided by Promega Corp. (Promega GmbH, Mannheim, Germany) and the statistical software package SPSS (Version 12.0; SPSS Inc., Chicago, IL, USA).
Results
PCR-SSP-based genotyping for the ABO polymorphisms 261G>del, 802G>A, 803G>C and 1061C>del was performed on 1,335 samples of an anonymized blood donor DNA bank. Unambiguous results could be obtained for all samples (table  2) . Each of the 4 polymorphisms fulfilled the Hardy-Weinberg
Introduction
After the discovery of the Mendelian inheritance of the ABO blood group system by von Dungern and Hirschfeld in 1910 [1] , blood group phenotyping including further systems has been introduced to paternity investigation [2] . For more than 60 years investigation of blood group systems and the HLA system represented the standard in forensic genetics. This serological era was then replaced by molecular genetics through the introduction of DNA fingerprints first on the basis of minisatellite (i.e. variable number of tandem repeat; VNTR) polymorphisms, later by the analysis of microsatellite (i.e. short tandem repeats; STR) polymorphisms [3] . Recent efforts led to the introduction of single nucleotide polymorphism (SNP) typing for human identification [4] . The ABO gene is located on the long arm of human chromosome 9 and consists of 7 exons. Exons 6 and 7 encode the major proportion including the catalytic domain of the glycosyltransferases that mediate the expression of A and B antigens [5, 6] . A number of studies have shown a clear genotypephenotype correlation [7] [8] [9] , and more than 240 gene variants are listed in the open access database dbRBC at the NCBI website [10] . Most of the gene variants are characterized by one or more SNPs leading to amino acid changes or stop codons. In addition, some variants result from nucleotide insertions or deletions (indels) mostly leading to a frame shift of the reading frame and subsequent alteration of the encoded amino acid sequence. The ABO blood groups A 1 , A 2 , and B result from the wild type allele ABO*A101 and the major variant alleles ABO*A201, and ABO*B101. The O phenotype is mostly caused by deletional O alleles such as ABO*O01 or ABO*O02 each characterized by the indel polymorphism 261G>del in exon 6. The most common non-deletional O allele is ABO*O03 with a point mutation in exon 7 also leading to the O phenotype (table 1) .
In the present study we determined the frequencies of the major ABO alleles in a representative German population by using PCR with sequence-specific primers (PCR-SSP). We then used serologic and genetic ABO blood grouping in paternity trios (child, mother, alleged father) in order to compare paternity likelihood (PL) and power of exclusion (PE) of both blood grouping approaches. 
No difference to the wild type (wt) allele *A101; italic letters/numbers indicate the gene polymorphisms used for ABO blood group genotyping in the present study. In the 60 cases with confirmed paternity, both PL and PE of the ABO genotype was significantly higher than those of the ABO phenotype (table 5) . Only in three cases where the child's ABO phenotype was B and the mother's phenotype was A or O the PE of the ABO genotype was slightly lower compared to the ABO phenotype (80.9% vs. 84.8%). In summary, the ABO genotype was superior to the ABO phenotype in all 95 paternity trio cases.
Discussion
In our study we determined the prevalence of the major ABO gene variants in a population of German blood donors. Four diallelic markers were determined by PCR-SSP with optimized sensitivity in order to reduce DNA consumption [12] . The ABO genotype could be obtained from less than 50 ng genomic DNA. However, the impact of DNA degradation on ABO genotyping by PCR-SSP has not been investigated so far. The genotypes were used to deduce the corresponding ABO blood group phenotype, and we found 99.7% genotypephenotype correlation for our low-resolution genotyping approach. The frequency of the different blood groups in our cohort corresponded to the expected frequencies (A 43%; B 9%; AB 4%; O 44%) for Caucasian populations [13] . Thus, we conclude that our study cohort is a representative sample equilibrium. The 261del variant characteristic for the majority of O alleles was the most prevalent variant of the ABO gene (1,590 of 2,670 alleles; 59.6%). Absence of all four variants indicated the presence of the wild type A1 allele. However, mutations at other sites of the ABO gene cannot be excluded by the low-resolution genotyping.
In order to determine the specificity of the low-resolution genotyping approach we compared the ABO blood group phenotype (A, B, AB, or O) registered in the blood donor files with the determined genotype. Blood groups A, B, and AB revealed a 100% phenotype/genotype correlation with the different genotypes (table 3). For 519 of the 523 samples (99.2%) with blood group O, we could determine a corre- ABO alleles could even strengthen this finding; however, analysis of further SNPs would be necessary to identify such alleles. The O02 allele is a common variant of the O01 allele carrying the indel polymorphism 261G>del in exon 6 and nine additional nucleotide changes in exons 2-7. It was shown that the O02 allele accounts for approximately 40% of O alleles [14] . The differential typing for O01 and O02 alleles would further enhance the statistical power of ABO genotyping, but was not performed in this study. Using a theoretical allele frequency of 0.41 of the O01 and 0.18 of the O02 allele in our population and assuming Hardy-Weinberg equilibrium for all alleles we re-calculated the statistical parameters. Discrimination of O01 and O02 alleles further increased the observed heterozygosity to 0.6856 (before 0.5775), PIC to 0.7025 (before 0.5380), PD to 0.8925 (before 0.7803), and PE to 0.4064 (before 0.2648). These values are similar to those reported in ABO genotyping of a small (n = 60) Italian cohort [15] . We assume that discrimination between the O01 and O02 alleles is reasonable and could be performed by typing a further SNP such as 646T>A or 681G>A in exon 7 of the ABO gene. Typing of highly polymorphic STR markers is the current worldwide standard in kinship analysis and forensic case work. The high PD and PE for each STR marker enable a reliable determination of paternity. Other marker systems such as blood groups, HLA, or RFLPs became uncomely due to the lower statistical power and higher labor input. However, the reasonable mutation rates of up to 1% of each STR of the German population. A2 (87.61%) C = Child; M = mother; AF = alleged father. *PE, power of exclusion; in cases with the dominant phenotype A 1 for child and mother all paternal blood groups are possible (no exclusion). [17] or other procedures [18] would require even lower DNA amounts. Finally, for the development of systems for genetic identity testing based on diallelic markers, we would recommend to combine anonymous SNPs and SNPs associated with an easyto-determine phenotype such as blood groups or HLA. This could open a new field of clinical application of genetic identity testing, e.g. where the identity of a hematopoietic stem cell transplant shipped from the donation site to the transplantation center is rechecked. rate per meiosis of diallelic markers including SNPs is estimated to be 100,000 times lower compared to STRs. Therefore, the reliability of SNP-based kinship analysis is higher and could probably replace STR-based analysis in future. By using ABO blood grouping in paternity trio cases we could show that ABO genotyping is superior to phenotyping with regard to statistical parameter such as PL and PE. In 12 of 35 trios (34.3%) where paternity was excluded by at least 5 of 12 STR markers, the ABO genotype also excluded paternity. The ABO phenotype could exclude paternity in only 20% of the cases. However, we must point out that neither ABO genotyping nor ABO phenotyping is sufficient for valid paternity testing. It should be regarded as an supplementary and optional approach to add further value to paternity cases based on STR systems.
Since the discovery of SNPs as the genetic basis of the ABO and of many other blood groups, SNP typing could probably bring back blood grouping to paternity testing on a molecular genetic basis. For this purpose the genotype-phenotype correlation is an important prerequisite and has been demonstrated for many different blood group systems including ABO, Rh, Duffy, MNS, Kidd, and Kell. Identification of individuals using anonymous SNPs on different chromosomes such as the SNPforID markers [4] could be combined with SNPs of different blood group systems. In selected cases and in terms of control purposes, i.e. to match a blood sample with a DNA sample, the phenotypes of blood groups on different chromosomes could provide useful information. Phenotyping and genoytping of HLA antigens could be used as well.
The application of SNP typing in a routine laboratory such as clinical diagnostics or paternity testing requires proof of reliability of the method and standardization of the procedure. In
